Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring

Core Insights - Movano Health has achieved a positive outcome from a recent meeting with the FDA regarding the EvieMED Ring's wellness features, allowing the company to proceed with the review process for this innovative healthcare product [1][2] - The EvieMED Ring is designed to provide both medical device functionality, such as pulse oximetry, and various wellness metrics related to sleep, activity, and mood [1][2] - Movano Health plans to resume direct-to-consumer (D2C) orders for the Evie Ring on September 17, 2024, featuring enhancements in sleep, activity tracking, and operational processes [3] Company Overview - Movano Health, founded in 2018, focuses on developing healthcare solutions that deliver medical-grade data through wearable devices, aiming to provide personalized health insights [4] - The company's technology is intended to proactively monitor and manage health outcomes across various patient populations [5]